Search filters

List of works by Slim Fourati

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure

article

A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infection

scientific article published in Nature Communications

Adjuvant Dependent Mucosal V2 Responses and RAS Activation in Vaccine Induced Protection from SIVmac251 Acquisition.

scientific article published in October 2014

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

scientific article published on 30 May 2016

Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study

scientific article

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

scientific article published on 3 January 2015

Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartments

scientific article published on February 2014

E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

scientific article published in August 2012

E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations

scientific article published on 25 November 2011

Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition

scientific article published on 12 March 2020

Erratum: Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

scientific article published on 01 October 2016

Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy

scientific article

Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists

scientific article

Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody

scientific article published on 20 July 2020

Frequency of amino acid changes associated with resistance to attachment inhibitor BMS-626529 in R5- and X4-tropic HIV-1 subtype B.

scientific article

HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis

article

HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs

scientific article published on 11 June 2012

Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies

scientific article published on 19 July 2013

Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia

scientific article published on 26 January 2011

Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors

scientific article published on 7 June 2013

Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage

scientific article published on 8 June 2015

Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine

article

Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy

scientific article published on 06 July 2021

Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 years

article

Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1

scientific article published on 17 September 2021

Mucosal effects of tenofovir 1% gel

scientific article (publication date: 3 February 2015)

Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

scientific article published on 20 June 2023

Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals

scientific article published on September 2010

Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir

scientific article published on 31 January 2011

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination

scientific article published on 8 January 2016

Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients

article

Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks

scientific article

The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype.

scientific article published on 19 September 2011

The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination

scientific article published on 23 September 2021

Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiation.

scientific article published on November 2014

Very early ART resulting in the absence of HIV-1 antibodies and in a sustained undetectable plasma HIV-1-RNA and proviral-DNA in an HLA-B*5701 and Δ32 heterozygote HIV-1-infected patient was not associated with functional cure

scientific article published on 19 September 2014

Paulina is supported by:

About Paulina

Help